Information Library
Results for: Consulting - Europe - United Kingdom
In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions. Search our library today.
- Sort by:
- Recently Added
- Title
-
Quintiles Backs Change to Marketing Mix as NHS Reforms Take Hold
Press Release — READING, UK – 30 May, 2012 – Quintiles has released the first in a series of briefing papers looking at how market access strategies can
-
UK Market Access Insight Brief
White Paper — May 30, 2012
Insight Briefing series on Market Access in key European countries -
UK Market Access Insight Brief
Hear from the Experts — May 30, 2012
Quintiles' Robert Taylor and Gareth Williams discuss the impact of healthcare reform on commercialisation strategy for the UK. -
UK Market Access Insight Brief
Podcast — May 30, 2012
Insight Briefing series on Market Access in key European countries -
ISPOR Europe 2012
Event — Conference Date(s): November 3 - November 7, 2012
Location: Berlin, German
-
Quintiles and Population Genetics Technologies Partner
Press Release — May 16, 2011 – Quintiles, and Population Genetics Technologies Ltd. (PGT), announced a commercial collaboration to bring genomic testing into mainstream drug development in order to produce safer, more effective medicines.
-
Dr. Frank Massam
Hear from the Experts — May 13, 2011
Dr. Frank Massam discusses the significance of Quintiles' partnership with Population Genetics Technologies Ltd. -
Biomarkers in Alzheimers Disease
Presentation — March 17, 2011
The Quintiles Innovation Unit shares their knowledge on the use of biomarkers in compound development in clinical trials. -
25 Years of Regulation - and Still Failing - Risky Business, Chapter 4
Hear from the Experts — February 2, 2011
Chapter Excerpt from Risky Business: Managing the Quality of America’s Medicines Chapter four identifies two simple principles needed for the improvement of quality management in pharmaceuticals today: managing consistency and maintaining responsiveness. -
Superior Teamwork - Renal Transplants
Case Study — February 2, 2011
901 patients were randomized according to the protocol timelines. The database lock was achieved 11 days before the original target date.

